Accenture has launched a new business service, known as Accelerated R&D Services, to accelerate drug development from discovery to approval to market. Focused on delivering streamlined and integrated research and development (R&D) ...
Tags: Drugs, R&D Service
Denmark-based pharmaceutical company H. Lundbeck has announced plans to enhance and simplify its commercial structure in Europe to boost its ability to launch new medicines. As per the plan, the project could result in elimination of up ...
Tags: Lundbeck, Europe, Health&Medicine
Pfizer has reached a $2.15bn settlement with Teva Pharmaceuticals Industries, and Sun Pharmaceutical Industries over Protonix patent-infringement lawsuit in the US. Following 10-years of litigation over the intellectual property for ...
Tags: Pfizer, Sun Pharma
Johnson & Johnson's Pharmaceuticals unit Janssen is planning to submit more than 10 new products for regulatory approval and extend the brand pipeline of 25 existing drugs by 2017. The late stage products to be submitted for approval ...
Tags: Johnson&Johnson, New Drugs
UK-based drug discovery and development company Redx Pharma is planning to open a new £10.5m research and development facility at AstraZeneca's Alderley Park site in Cheshire, England. The new venture, Redx Anti-Infectives, will ...
Tags: Redx Pharma, Medicine
GlaxoSmithKline (GSK) has announced a funding injection of up to £5m from the Wellcome Trust to support its open approach to discover and develop the treatments for certain diseases. The funding will move the early-stage research to ...
Tags: Glaxosmithkline, funding injection
Abide Therapeutics and Merck, referred to as MSD outside the US and Canada, have collaborated to develop new therapies for type 2 diabetes and metabolic diseases. The collaboration will focus on the discovery, development and ...
Tags: Abide Therapeutics, Medicine
The European Commission (EC) has granted conditional marketing authorization for Pfizer's Bosulif (bosutinib) anti-cancer drug in the European Union (EU). Bosulif is authorized in Europe for the treatment of adult patients with chronic ...
Tags: Pfizer Bosulif, cancer drug, drug
Six translational health research centers across the globe have formed an alliance to advance the global international academic and/or not-for-profit drug development. The alliance will also focus on commercializing network, thereby ...
Accenture has received a contract from the Italian Medicines Agency (AIFA) to develop, build and maintain an integrated Medicine Evaluation System. The company will provide the national authority that approves new medicines with ...
Tags: Accenture, Medicine Evaluation System, AIFA
AstraZeneca and Ardelyx have signed a worldwide exclusive licensing agreement for Ardelyx's NHE3 inhibitor programme for the treatment of complications associated with end-stage renal disease (ESRD) and chronic kidney disease (CKD). The ...
Tags: RDX5791, Ardelyx, AstraZeneca, NHE3 inhibitor programme, NHE3
Linguamatics has launched a new cloud-based clinical trials text mining solution, I2E. The platform is used for mining clinical trials data for decision support in biomedical research, clinical trials study design, site selection and ...
Tags: cloud-based clinical trials, Linguamatics, clinical platform
Ten biopharmaceutical companies, Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech and Sanofi have established a non-profit organization ...
Tags: biopharmaceutical companies, non-profit organization, new medicines